Administration of Bronchodilators Based on Astma score
- Conditions
- Asthma
- Registration Number
- NL-OMON29161
- Lead Sponsor
- Martini Hospital Groningen, The Netherlands
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 130
Inclusion Criteria
children 2-18 years of age admitted for acute asthma
-treatment for acute asthma according to current dutch guideline
-supplemental oxygen use, low flow or high flow
Exclusion Criteria
-severe acute asthma for which intravenous albuterol is indicated
-unstable heart disease
-cystic fbrosis or other chronich or congenital lung disease
-any neurological disease
-any muscular disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in admission time for children with acute asthma who are treated according to the current nurse-driven pathway or the new pathway with adjusted treatment thresholds for patients who need supplemental oxygen.
- Secondary Outcome Measures
Name Time Method -number of bronchodilator adminstrations per patient, <br>-the number of deviations from the pathway; administration of bronchodilators when not indicated or when bronchodilators were indicated but not administered. <br>-number or assessments by attending physician<br>-number of patients excluded because they needed treatment with intravenous albuterol <br>-number of re-admission within one week <br>-association between heart rate and the total CAS en individual items of CAS<br>-difference between groups in administration of intravenous magensiumsulphate<br>-difference between groups in transfer to pediatric intensive care unit